CG Oncology CEO highlights biotech’s oncolytic immunotherapy for bladder cancer August 23, 2021 Auto Bot BioPharma, biopharma nl, MedCitizens, Startups 0 CG Oncology CEO Arthur Kuan talked about the biotech company’s experimental bladder cancer treatment in Phase 3 development and collaboration with Merck, among the company’s milestones, in response to emailed questions.